Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,214 total articles

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

BIO-key International, a leader in biometric authentication and identity access management solutions, will hold its Q2 2026 investor call on August 14, 2026. The company provides multi-factor biometric security solutions serving over forty million users, emphasizing phoneless, tokenless, and passwordless authentication options for diverse applicati…

Plains All American Reports Second-Quarter 2026 Results

Plains All American Reports Second-Quarter 2026 Results

Plains All American Pipeline, L.P. (Nasdaq: PAA) and its parent Plains GP Holdings reported strong second-quarter 2026 financial results, highlighted by $1.830 billion net income attributable to PAA, including a $1.6 billion gain from the Canadian NGL Business divestiture. The company reduced debt by approximately $2.9 billion, achieving a pro form…

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

Treace Medical Concepts, a Nasdaq-listed medical technology company specializing in bunion surgical treatments, reported Q2 2026 revenue of $45.4 million, down 4% year-over-year, with a net loss of $15.9 million. The company reduced cash usage by 57% year-to-date and improved adjusted EBITDA loss slightly. It initiated limited releases of new produ…

Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update

Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update

Gyre Therapeutics announced its second quarter 2026 financial results, reporting Q2 revenue of $29.1 million and a GAAP basic loss per share of $0.12. The company affirmed its full-year 2026 revenue guidance of $100.5 to $111.0 million. Key business updates include the acceptance of the NDA for F351 (hydronidone) for chronic hepatitis B-induced liv…

Johnson Outdoors Reports Fiscal Third Quarter Results

Johnson Outdoors Reports Fiscal Third Quarter Results

Johnson Outdoors Inc. announced its fiscal third quarter results ending July 3, 2026, reporting a 5% increase in net sales to $189.7 million, driven primarily by strong performance in its Fishing and Diving segments. Operating income more than doubled to $18.3 million aided by tariff refunds, improved margins, and pricing actions. Year-to-date resu…

ARKO Corp. Reports Second Quarter 2026 Results

ARKO Corp. Reports Second Quarter 2026 Results

ARKO Corp., a major U.S. convenience store and fuel wholesaler operator, reported its Q2 2026 results with decreased net income but increased Adjusted EBITDA. The company reaffirmed its full-year Adjusted EBITDA guidance and highlighted progress on transformation initiatives including dealerization, remodels, and loyalty programs. Post-quarter, ARK…

Ultralife Corporation Reports Second Quarter Results

Ultralife Corporation Reports Second Quarter Results

Ultralife Corporation reported second quarter 2026 results featuring $47.9 million in sales, a slight 1.3% revenue decline from the prior year but an improved gross profit margin of 28.9%. The company achieved GAAP EPS of $0.15, tripling from $0.05 in the prior year quarter, and adjusted EBITDA rose 48% to $6.1 million. Backlog hit an all-time high…

FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval

FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval

NRx Pharmaceuticals announced that the FDA finished the first-cycle review of its ANDA application for preservative-free ketamine, identifying no major deficiencies related to the drug or its manufacturing, labeling, or chemistry. The only remaining issue pertains to packaging certification, specifically the luer lock vial, which is already used in…

WRAP Completes Training Foundation of WrapShield™ – WrapTactics™ Launches as the Operational Backbone of Non-Lethal Response

WRAP Completes Training Foundation of WrapShield™ – WrapTactics™ Launches as the Operational Backbone of Non-Lethal Response

Wrap Technologies announced the commercial launch of WrapTactics™, a Learning Management System that completes the training foundation of their WrapShield™ six-tier non-lethal response platform. Following ATF's classification of BolaWrap® 150 as a non-lethal instrument of restraint, WrapTactics™ provides essential training and certification, enabli…

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Rapid Micro Biosystems announced its financial results for Q2 2026, showing total revenue of $8.1 million, an 11% growth year-over-year, driven by increased placement and validation of Growth Direct systems. The company achieved record gross margins of 15%, improving significantly from the prior year, and reaffirmed its full-year 2026 revenue guida…

Purple Biotech Reports Second Quarter 2026 Financial Results

Purple Biotech Reports Second Quarter 2026 Financial Results

Purple Biotech Ltd. reported strong preclinical results for its tri-specific antibody candidate IM1240, demonstrating favorable anti-tumor activity, safety profile, and pharmacokinetics. The company is preparing for first-in-human clinical studies in 2027. With $6.1 million in cash as of June 30, 2026, Purple Biotech has a runway through mid-2027, …

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

Embecta Corp., a global medical supplies company with a century-long legacy in insulin delivery, has reported its third quarter fiscal 2026 financial results. The company provides detailed earnings information through its investor relations website and has scheduled a live webcast and conference call to discuss the results with analysts and investo…

Nathan's Famous, Inc. Reports First Quarter Results

Nathan's Famous, Inc. Reports First Quarter Results

Nathan's Famous, Inc. reported its first quarter fiscal 2027 results showing increased revenues driven by higher sales volume and price increases, particularly in the branded product segment. Despite a rise in revenue to $54.1 million, net income and earnings per diluted share slightly declined due to increased costs, notably a 22% surge in beef an…

American Solar Supported by Polysilicon Proclamation

American Solar Supported by Polysilicon Proclamation

T1 Energy Inc. supports the Trump Administration's decision to set minimum import prices on polysilicon and related products to protect the U.S. solar industry from market dumping, strengthen domestic manufacturing, and create high-quality American jobs. The company highlights its vertically integrated solar supply chain strategy with ongoing proje…

6-K_GRAVITY_Second QUARTER 2026 RESULT and Business Update

6-K_GRAVITY_Second QUARTER 2026 RESULT and Business Update

GRAVITY Co., Ltd., a South Korean online and mobile game developer listed on NasdaqGM under ticker GRVY, announced its Q2 2026 financial results, showing flat revenues compared to Q1 but a significant year-over-year increase in net profits. The company highlighted growth in online game revenues driven by the Ragnarok Online franchise in various reg…

Gray Media Announces Second Quarter Financial Results

Gray Media Announces Second Quarter Financial Results

Gray Media, Inc. announced its financial results for Q2 2026, highlighting a 9% increase in total revenue to $839 million, driven by successful acquisitions and a significant surge in political advertising revenue. The company improved its net leverage ratio and expanded its market presence by acquiring stations in 22 markets, including assets from…

ACM Research’s Ultra ECP ap-p Horizontal Panel Electroplating Tool Receives First Production Order and Evaluation Order from Customers

ACM Research’s Ultra ECP ap-p Horizontal Panel Electroplating Tool Receives First Production Order and Evaluation Order from Customers

ACM Research announced it has received the first production order and an evaluation order from advanced packaging customers for its Ultra ECP ap-p horizontal panel-level electroplating tool. The tool supports large panel formats and advanced plating processes, aiming to improve uniformity, stability, and production efficiency in semiconductor packa…

ACM Research Reports Second Quarter 2026 Results

ACM Research Reports Second Quarter 2026 Results

ACM Research, Inc. reported a 36% year-over-year increase in Q2 2026 revenue and shipments, driven by significant growth in electrochemical plating (ECP) and advanced packaging segments. The company achieved good profitability, shipped its 2,000th ECP chamber, and ended the quarter with $1 billion in net cash. ACM raised its full-year 2026 revenue …